Urgotul 99XX0071 Dressing, 5cm x 5cm, Pack of 10

Product Information

Parpex P. et al. Management of venous leg ulcers with Cellosorb Micro-adherent dressing: results of a multi-centre clinical trial. Phlebologie 2010; 63: 76-82. The UrgoTul range is designed to give every acute wound the best chance of healing. Using Lipido-Colloid technology healing matrix (hydrocolloid particles in a lipophilic substance), Urgotul dressings maintain moist wound environments, which are optimum for healing. These dressings also do not adhere to the wound bed, making removal atraumatic and pain-free. Indications: If the wound shows signs of significant bacterial colonisation, it is recommended that the bacterial component be treated first before starting treatment with UrgoStart. Meaume S. et al., Management of chronic wounds with an innovative absorbent wound dressing. J Wound Care, Vol 21, No 7; July 2012, 315-322. To prevent any risk of delay in appropriate treatment, UrgoStart is contraindicated in cancerous wounds and in fistular wounds demonstrating deep abscess formation.

Urgo Medical - The advanced wound care division of Urgo Group

UrgoTul is a non-occlusive flexible and conformable dressing comprising of a polyester mesh impregnated with Technology Lipido-Colloid (TLC) healing matrix. Leg ulcers, diabetic foot ulcers and pressure ulcers take an average of 210 days* to heal. (2) *CNAM database: leg ulcers: 210 days; pressure ulcers: 223 days; diabetic foot ulcers: comparative data not available. Meaume S, Ourabah Z, Charru P, Meyer P, Perez J, Sauvadet A, Bohbot S. Meaume S, et al. Br J Nurs. 2007 Mar 22-Apr 11;16(6):S4, S6, S8 passim. doi: 10.12968/bjon.2007.16.Sup1.27088. Br J Nurs. 2007. PMID: 17505400 Clinical Trial. Shown to be effective against bacteria most frequently associated with wound infections: Staphylococcuss aureus, Streptococcuss pyogenes, Pseudomonas aeruginosa (pyocyanic bacillus), MRSA, Enterococcus faecalis VRE, Escherichia coli and Candida albicans (1) Prepare the wound according to local protocol. If an antiseptic is first used, rinse the wound thoroughly with saline solution before applying UrgoTul.Meaume S, et al. Use of a new, flexible lipidocolloid dressing on acute and chronic wounds: results of a clinical study. J Wound Care. 2011;20(4):180,182-5.

Urgo Medical | URGOStart

UrgoTul Absorb is indicated for all exuding chronic wounds (leg ulcers, pressure ulcers, diabetic foot ulcers), acute wounds (2nd degree burns, skin abrasions, traumatic wounds, post-operative wounds….) and for the local treatment of fungating wounds in combination with a specific treatment. Bernard FX et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloïd dressing. Journal of Wound Care, May 2005; 14 (5): 215-220 (study conducted on Urgotul). The UrgoTul range is designed to give every acute wound the best chance of healing. Using our Technology Lipido-Colloid (TLC) healing matrix (hydrocolloid particles in a lipophilic substance), UrgoTul dressings: Remove the side tabs and carefully apply the side parts of the dressing to either side of the foot.If required UrgoTul Absorb and UrgoTul Absorb Heel can be cut using sterile equipment to adjust the size of the dressing to fit the wound. UrgoTul dressings should be changed every 2 to 4 days, depending on the wound to be treated and its clinical condition. UrgoTul can be left in place for up to 7 days under multilayer compression in venous leg ulcers. UrgoClean can be cut using sterile scissors to adjust the size of the dressing to the wound if necessary